NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
Loading market information…
BSE · DRAGARWQ.BO · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:52 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Dr. Agarwal's Eye Hospital Limited’s quoted price sits in the lower half of its reported 52-week range, 17.39% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Dr. Agarwal's Eye Hospital Limited’s forward annual dividend is ₹8.00 per share, paid semi-annual. The forward yield is 0.15% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Dr. Agarwal's Eye Hospital Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Dr. Agarwal's Eye Hospital Ltd. is a specialized medical facility offering a comprehensive range of ophthalmic services. Its extensive offerings span various specialties, encompassing cataract surgery, advanced corneal interventions (including LASIK and SMILE), retina treatment, orbit and oculoplasty, glaucoma management, uvea care, neuro-ophthalmology, pediatric ophthalmology, and strabismus correction, alongside optical dispensing. Beyond patient care, the hospital is committed to ongoing professional development through continuous training and actively participates in research and development initiatives. The company was established in 1957 by Jaiveer Agarwal, Tahira Agarwal, Amar Agarwal, and Athiya Agarwal, and maintains its primary operational base in Chennai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Oct 29, 2024 | ₹30.11+399.34% vs estimate | ₹1.02B+121.21% vs estimate |
|---|
| Q1 2025 | Jul 25, 2024 | ₹30.02 | ₹1.00B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹9,780.00+₹116.00 (+1.2%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
₹4,613.40+₹33.40 (+0.73%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.13% below the high.
₹2,405.50+₹161.50 (+7.2%)
Laurus Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
₹1,245.50+₹61.10 (+5.16%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 0.27% below the high.
₹8,448.00+₹248.00 (+3.02%)
Apollo Hospitals Enterprise Limited’s quoted price sits in the upper half of its reported 52-week range, 6.86% below the high.
₹506.10+₹17.40 (+3.56%)
Dr. Agarwal's Health Care Limited’s quoted price sits in the upper half of its reported 52-week range, 10.86% below the high.
₹109.50-₹0.50 (-0.45%)
Lotus Eye Hospital and Institute Limited’s quoted price sits in the lower half of its reported 52-week range, 25.51% below the high.
